25 of the Best Hematologist Oncologists Near Me in charleston, SC

Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Orchiectomy. Dr. Ho is currently accepting new patients.

Robert Stuart is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Stuart is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Abirami Sivapiragasam is a board-certified hematologist and oncologist with over a decade of experience. Currently, she is the Director of Medical Oncology at the MUSC Hollings Cancer Center and an Associate Professor of Medicine at the Medical University of South Carolina. Previously, she worked as an Associate Professor of Medicine at the SUNY Upstate Medical University Hospital in Syracuse, NY. During her tenure there, she also served as the Program Director for the Hematology and Oncology Fellowship program.Dr. Sivapiragasam is an expert in the diagnosis and treatment of breast cancer. She is also a skilled educator, having trained medical students, residents, and fellows.As a member of the American Society of Clinical Oncology and the American Board of Internal Medicine, Dr. Sivapiragasam is committed to keeping up with the latest advancements in her field. Additionally, she is a published researcher in her area of expertise.Dr. Sivapiragasam is known for her compassionate and dedicated approach to patient care. She is a respected leader in the field of breast oncology and is highly regarded in the medical community. Dr. Sivapiragasam is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Laryngeal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Sivapiragasam is currently accepting new patients.

Alexander Coltoff, M.D. received his medical degree from SUNY Downstate College of Medicine. He then completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, followed by a fellowship in Hematology/Oncology at New York Presbyterian - Columbia, both in New York. His clinical and research focus is on hematologic malignancies, particularly myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). He has been published as a clinical investigator and received an American Society of Hematology (ASH) award for developing research scientists. Dr. Coltoff is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Coltoff is currently accepting new patients.

Dr. Katherine Antel earned her medical degree from the University of Cape Town, South Africa and where she went on to complete an internal medicine residency and a fellowship in hematology and bone marrow transplant. Dr. Antel went on to pursue 3-year research fellowship in lymphoid genomics at the Dana-Farber Cancer Institute, Boston U.S. Her research area of interest is in lymphoid biology, and lymphoid genomics. Dr. Antel is an associate professor at the Medical University of South Carolina in Charleston. Her clinical and research areas of interest include the biology and genomics of aggressive lymphoma and the development of clinical assays to detect and diagnose lymphoma using cell-free DNA. Dr. Antel is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lymphofollicular Hyperplasia, Lymphadenitis, Hodgkin Lymphoma, and Burkitt Lymphoma. Dr. Antel is currently accepting new patients.

Dr. Jenkins obtained his Bachelor's degree in biology at the University of Virginia in 2002 and his MD/PhD at the Medical University of South Carolina in 2012. He completed his internship and residency in Internal Medicine at Massachusetts General Hospital in 2014 and his clinical oncology training in the Dana-Farber/Harvard Cancer Center in 2017. He conducted his post-doctoral research in Dr. David Barbie's lab at the Dana-Farber Cancer Institute where he developed a novel platform to study ex vivo response to PD1- blockade using organotypic tumor spheroids. In 2018, he joined the faculty at the MGH Cancer Center in the Center for Melanoma and Center for Cancer Research and was an Associate Member of the Cancer Program at the Broad Institute of MIT and Harvard. Dr. Jenkins was the inaugural Termeer Early Career Investigator in Systems Pharmacology, and member of the Laboratory for Systems Pharmacology at Harvard Medical School. Dr. Jenkins returned to MUSC in 2025 as the Cecilia and Vincent Peng Endowed Chair in Melanoma and Cutaneous Oncology with appointments in the Department of Medicine, Division of Hematology-Oncology, Department of Dermatology and Dermatologic Surgery, and Department of Pharmacology \& Immunology. The Jenkins laboratory studies mechanisms of response and resistance to immune checkpoint blockade and adoptive cellular therapy with a focus on developing rational combination therapies to overcome resistance to cancer immunotherapy. Dr. Jenkins is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, and Melanoma of the Eye. Dr. Jenkins is currently accepting new patients.

Shayla Bergmann is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Bergmann is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, and Hemolytic Anemia. Dr. Bergmann is currently accepting new patients.

Christina Abrams is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Abrams is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, and Hemolytic Anemia. Dr. Abrams is currently accepting new patients.

Jacqueline Kraveka is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Kraveka is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Sickle Cell Disease. Dr. Kraveka is currently accepting new patients.

Sherron Jackson is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Jackson is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Jackson is currently accepting new patients.

David Ellison is an Oncologist practicing medicine in Charleston, South Carolina. Dr. Ellison is highly rated in 69 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Chromophobe Renal Cell Carcinoma, and Gastrostomy. Dr. Ellison is currently accepting new patients.

Anthony Dominick, D.O., was born and raised in Kansas City before moving to Chicago, IL, to earn his Bachelor of Science in Biology at Loyola University. He received his medical degree from Lake Erie College of Osteopathic Medicine in Bradenton, FL. He then moved back to his hometown of Kansas City to complete his residency in internal medicine and fellowship in hematology and oncology at The University of Kansas Medical Center. Early on in his training, he was inspired by his mentors and developed a passion for malignant hematology. After completing training, he spent four years in private practice caring for patients with hematologic conditions in eastern North Carolina. He joined MUSC to pursue his interest and passion for caring for patients with multiple myeloma. He also has a secondary clinical interest in lymphoproliferative disorders. Dr. Dominick is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Dominick is currently accepting new patients.

Lauren Pearce, FNP, specializes in Hematology/Oncology, and Blood & Marrow Transplant and is located in Charleston, SC. Dr. Pearce is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Diffuse Large B-Cell Lymphoma (DLBCL), and Large-Cell Immunoblastic Lymphoma. Dr. Pearce is currently accepting new patients.

Dr Ashwath Gurumurthi is an Assistant Professor at the Medical University of South Carolina in Charleston. He completed his medical degree at The University of Western Australia (Perth, Australia) followed by internal medicine residency and a dual fellowship in clinical and laboratory hematology in Australia. Dr Gurumurthi furthered his experience in lymphoma and cellular therapies through advanced fellowships in MD Anderson Cancer Center (Texas) and Memorial Sloan Kettering Cancer Center (New York). His clinical and research interests focus on T-cell lymphoma and relapsed lymphomas. He is dedicated to advancing innovative treatment strategies to address critical unmet needs in hematologic oncology, while mentoring the next generation of physicians. Dr. Gurumurthi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Febrile Neutropenia, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Mantle Cell Lymphoma (MCL).

George Geils is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Geils is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Colorectal Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Geils is currently accepting new patients.

Brian Lingerfelt is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Lingerfelt is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Familial Colorectal Cancer, Paget Disease of the Breast, and Colorectal Cancer. Dr. Lingerfelt is currently accepting new patients.

Irl Greenwell is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Greenwell is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Histiocytosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Greenwell is currently accepting new patients.

Shelly Shand is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Shand is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, and Multiple Myeloma. Dr. Shand is currently accepting new patients.

Sandeepkumar Kuril is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Kuril is highly rated in 1 condition, according to our data. His clinical expertise encompasses Sickle Cell Disease, Dysembryoplastic Neuroepithelial Tumors (DNET), Hemoglobinopathy, and Hemoglobin SC Disease. Dr. Kuril is currently accepting new patients.

Dr. Bechhold practiced for over 30 years in Cincinnati as a partner in one of the largest private oncology groups in the country. The group had a robust clinical trials program and she headed several breast cancer trials. She also served on numerous professional and community organizations, edited the Medical Society magazine, was a writer for Cancer- a journal for oncologists, and a popular public speaker. She served as Medical Director for one of the largest hospice programs in the country for 27 years. She was named a Woman of the Year by the Cincinnati Enquirer and a Career Woman of Achievement by the YWCA.Dr. Bechhold is passionate about helping cancer patients understand their disease and how to manage the treatment options to their best outcome.She and her husband, Chris, raised two daughters. Dr. Bechhold is thrilled to be in Charleston where she loves to play tennis, golf, and do needlepoint. She is an avid reader and writes a book column for the Daniel Island News as well as publishing a reading blog. Her clinical expertise encompasses Lynch Syndrome, Colorectal Cancer, Familial Colorectal Cancer, and Angiosarcoma. Dr. Bechhold is currently accepting new patients.

Dr. Steven Akman has been practicing hematology-oncology for more than 43 years. During his long career, he has taken care of patients with a range of non-malignant hematologic conditions, malignant hematologic conditions, and solid tumors. His area of emphasis has been in the medical oncologic management of breast cancer. He directed the Breast Cancer Center of Excellence of the Wake Forest University Comprehensive Cancer Center for 17 years.His wealth of experience allows him to bring maturity, patience, insight, and empathy to every patient interaction. He plans to spend the next five years taking care of hematology/oncology patients in the outpatient setting. His goal is to provide every patient with the highest possible quality of care and the educational and emotional support required for an effective partnership. Providing the highest possible quality of care includes the opportunity to provide access to clinical trials. His clinical expertise encompasses Thrombocytopenia, Breast Cancer, Lung Cancer, and Iron Deficiency Anemia. Dr. Akman is currently accepting new patients.

Dr. Mohammad Alhousani is an Assistant Professor of Medicine at the Medical University of South Carolina (MUSC) with expertise in lymphomas and related B- and T-cell disorders, including both aggressive and indolent non-Hodgkin lymphomas, Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrm macroglobulinemia, and central nervous system (CNS) lymphoma. Dr. Alhousani's clinical and research interests focus on bringing the latest advances in lymphoma care to his patients. He has a particular interest in CAR T-cell therapy, bispecific antibodies, clinical trials, and blood and marrow transplantation for patients with lymphoma. His approach emphasizes integrating innovative therapies with personalized, compassionate care tailored to each patient's needs and goals. He completed his internal medicine residency at Marshall University and his hematology and oncology fellowship at Allegheny Health Network (AHN). He then pursued an advanced fellowship in Blood and Marrow Transplantation at Mayo Clinic in Rochester, Minnesota, where he was deeply involved in the care of patients with lymphoma and CAR T-cell therapy. Dr. Alhousani is committed to advancing the field of lymphoma and cellular therapy through clinical research, multidisciplinary collaboration, and a patient-centered approach to cancer care. His clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML) and Bone Marrow Transplant.

Jonathan Alexander, M.D. was born and raised in Cape Town, South Africa, before moving to the United States to begin his medical training. He received a Master of Science from Columbia University College of Physicians and Surgeons in New York City. He then received his medical degree from St George's University School of Medicine, where he graduated Magna Cum Laude. He completed his internal medicine residency at the University of Louisville School of Medicine, followed by a fellowship in Hematology/Oncology at the Medical University of South Carolina. He chose to pursue an additional year of training at Stanford University in California, where he completed a fellowship in Bone Marrow Transplant and Cellular Therapy. His clinical and research interests include myeloid neoplasms, focusing on acute myeloid leukemia and bone marrow transplant. His clinical expertise encompasses Marginal Zone Lymphoma (MZL), Kaposi Sarcoma, Myelofibrosis, and Acute Myeloid Leukemia (AML). Dr. Alexander is currently accepting new patients.

Dr. Edwards is a medical oncologist dedicated to caring for breast cancer patients. Her journey began in the Republic of Georgia, where she earned her M.D. degree with honors from Tbilisi State Medical University and was recognized for her academic achievements with a Silver Medal from the Ministry of Public Education. Following training in obstetrics and gynecology in Georgia and the United Kingdom, she relocated to the United States to pursue further medical education.Dr. Edwards obtained her D.O. from the New York College of Osteopathic Medicine and completed her internal medicine residency at the University of Buffalo, where she also conducted clinical research at the Roswell Park Comprehensive Cancer Center. Her medical training culminated in a Hematology and Medical Oncology fellowship at the University of Rochester Medical Center.Dr. Edwards was recognized for her contributions to the field and was awarded the Segel-Halterman Award for Research in Medical Oncology in 2023. Her passion lies in providing compassionate and comprehensive care to breast cancer patients, offering hope and guidance throughout their treatment journey. At Holling Cancer Center, she collaborates closely with a multidisciplinary team to deliver exceptional care and achieve optimal outcomes. Her clinical expertise encompasses Marginal Zone Lymphoma (MZL) and Breast Cancer.

Dr. Sanjay Jain is amongst the new faculty members to join Medical University of South Carolina as a Professor in the Department of Internal Medicine. Dr. Jain is a medical oncologist with 26 years of academic and clinical experience. He is interested in the provision of clinical services to patients that are unquestionably and unconditionally par excellence. He's a firm believer that patient satisfaction should be a key measure of success and patient outcomes should be superior to national and international benchmarks. Dr. Jain was born in Kota, Rajasthan, India. He received his M.B., B.S. (Medicine and Surgery) from the University of Rajasthan, Jaipur, India, and was recognized as the best Intern at Maharao Bhim Singh Hospital. He obtained his M.S. degree and his Ph.D., both in immunology, from Kent State University in Kent, Ohio. Dr. Jain's residency training in the United States took place at Miriam Hospital, Brown University in Providence, Rhode Island, and he also did a fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston, Massachusetts. Prior to coming to Medical University of South Carolina, Dr. Jain served as an Assistant Professor at Winship Cancer Institute of Emory University, Assistant Professor at Beth Israel Deaconess Medical Center of Harvard Medical School, Chairman of the Department of Hematology and Oncology at Tawam Hospital, in affiliation with Johns Hopkins in the United Arab Emirates, and Assistant Professor at Johns Hopkins University, and then most recently as an Associate Professor at Morehouse School of Medicine. He has also served as a medical oncologist and a reviewer of first-in-human trials at the Center for Biologics Evaluation and Research at the Food and Drug Administration since 2021. Dr. Jain is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Jain is currently accepting new patients.